These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9521739)

  • 1. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
    Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
    Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of inactivation of inducible nitric oxide synthase by amidines. Irreversible enzyme inactivation without inactivator modification.
    Zhu Y; Nikolic D; Van Breemen RB; Silverman RB
    J Am Chem Soc; 2005 Jan; 127(3):858-68. PubMed ID: 15656623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine.
    Bryk R; Wolff DJ
    Biochemistry; 1998 Apr; 37(14):4844-52. PubMed ID: 9538001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
    Bryk R; Lubeskie A; Wolff DJ
    Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.
    Hallinan EA; Hagen TJ; Bergmanis A; Moore WM; Jerome GM; Spangler DP; Stevens AM; Shieh HS; Manning PT; Pitzele BS
    J Med Chem; 2004 Feb; 47(4):900-6. PubMed ID: 14761191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of substrate-analogue inhibitors on nitric oxide synthase dimerization.
    Lee KS; Lee DK; Jeoung D; Lee H; Choe J; Ha KS; Won MH; Kwon YG; Kim YM
    Biochem Biophys Res Commun; 2012 Feb; 418(1):49-55. PubMed ID: 22240022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of nitric oxide synthases and cellular nitric oxide formation by N6-iminoethyl-L-lysine and N5-iminoethyl-L-ornithine.
    Wolff DJ; Lubeskie A; Gauld DS; Neulander MJ
    Eur J Pharmacol; 1998 Jun; 350(2-3):325-34. PubMed ID: 9696424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells.
    Cooper GR; Barr A; Wolff DJ
    Arch Biochem Biophys; 1998 Sep; 357(2):195-206. PubMed ID: 9735160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase.
    Sennequier N; Stuehr DJ
    Biochemistry; 1996 May; 35(18):5883-92. PubMed ID: 8639550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo.
    Stenger S; Thuring H; Rollinghoff M; Manning P; Bogdan C
    Eur J Pharmacol; 1995 Dec; 294(2-3):703-12. PubMed ID: 8750736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
    Ichimori K; Stuehr DJ; Atkinson RN; King SB
    J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural product noformycin is an inhibitor of inducible-nitric oxide synthase.
    Green BG; Chabin R; Grant SK
    Biochem Biophys Res Commun; 1996 Aug; 225(2):621-6. PubMed ID: 8753809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.
    Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C
    J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide.
    Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
    J Periodontal Res; 2007 Apr; 42(2):124-30. PubMed ID: 17305870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
    Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
    Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.
    Hansel TT; Kharitonov SA; Donnelly LE; Erin EM; Currie MG; Moore WM; Manning PT; Recker DP; Barnes PJ
    FASEB J; 2003 Jul; 17(10):1298-300. PubMed ID: 12738811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine.
    Walker LM; Walker PD; Imam SZ; Ali SF; Mayeux PR
    J Pharmacol Exp Ther; 2000 Oct; 295(1):417-22. PubMed ID: 10992009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
    Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
    Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-site structure analysis of recombinant human inducible nitric oxide synthase using imidazole.
    Chabin RM; McCauley E; Calaycay JR; Kelly TM; MacNaul KL; Wolfe GC; Hutchinson NI; Madhusudanaraju S; Schmidt JA; Kozarich JW; Wong KK
    Biochemistry; 1996 Jul; 35(29):9567-75. PubMed ID: 8755738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
    Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
    J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.